SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts / Institutional Investors Conference Call SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Cancellation of Analysts / Institutional Investors Conference Call SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts / Institutional Investors Conference Call SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Notice To Shareholders Holding Shares In Physical Mode Requesting To Furnish PAN, KYC Details And Registration Of Nomination
Notice to Shareholders holding Shares in Physical Mode requesting to furnish PAN, KYC details and registration of nomination SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts / Institutional Investors Conference Call SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts / Institutional Investors Conference Call SUDARSHAN CHEMICAL INDUSTRIES LTD. - 506655 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information for loss of share certificate(s) / issue of duplicate share certificate(s)
Buy Sudarshan Chemical ; target of Rs 695: ICICI Direct
ICICI Direct is bullish on Sudarshan Chemical recommended buy rating on the stock with a target price of Rs 695 in its research report dated January 26, 2022.
Earnings Call for Q3FY22 of Sudarshan Chemical Industries
Conference Call with Sudarshan Chemical Industries Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.